↑ 薬物リストへ　← 戻る

Daratumumab injection    (DrugBank: Daratumumab)

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
16クロウ・深瀬症候群1

16. クロウ・深瀬症候群　［臨床試験数：12，薬物数：18（DrugBank：8），標的遺伝子数：5，標的パスウェイ数：79］
Searched query = "Crow-Fukase syndrome", "POEMS syndrome", "Polyneuropathy, organomegaly, endocrinopathy, m-protein, and skin changes syndrome", "Takatsuki disease", "PEP syndrome", "Polyneuropathy, endocrinopathy, plasma cell dyscrasia syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 12 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04396496
(ClinicalTrials.gov)		September 22, 202015/5/2020Treatment of POEMS Syndrome With DaratumumabA Phase II Trial for the Treatment of POEMS Syndrome With DaratumumabPOEMS SyndromeDrug: Daratumumab InjectionUniversity of ArkansasJanssen Scientific Affairs, LLCRecruiting18 YearsN/AAll10Phase 2United States